Skip to main content

Peer Review reports

From: Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study

Original Submission
13 Oct 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Nov 2021 Author responded Author comments - Shoji Kawashima
Resubmission - Version 3
21 Nov 2021 Submitted Manuscript version 3
28 Nov 2021 Author responded Author comments - Shoji Kawashima
Resubmission - Version 4
28 Nov 2021 Submitted Manuscript version 4
3 Dec 2021 Author responded Author comments - Shoji Kawashima
Resubmission - Version 5
3 Dec 2021 Submitted Manuscript version 5
26 Dec 2021 Reviewed Reviewer Report - Yuhu Zhang
27 Dec 2021 Reviewed Reviewer Report
11 Jan 2022 Author responded Author comments - Shoji Kawashima
Resubmission - Version 6
11 Jan 2022 Submitted Manuscript version 6
23 Jan 2022 Author responded Author comments - Shoji Kawashima
Resubmission - Version 7
23 Jan 2022 Submitted Manuscript version 7
11 Feb 2022 Reviewed Reviewer Report
10 Apr 2022 Author responded Author comments - Shoji Kawashima
Resubmission - Version 8
10 Apr 2022 Submitted Manuscript version 8
13 Apr 2022 Author responded Author comments - Shoji Kawashima
Resubmission - Version 9
13 Apr 2022 Submitted Manuscript version 9
19 Apr 2022 Author responded Author comments - Shoji Kawashima
Resubmission - Version 10
19 Apr 2022 Submitted Manuscript version 10
Publishing
4 May 2022 Editorially accepted
13 May 2022 Article published 10.1186/s12883-022-02699-x

You can find further information about peer review here.

Back to article page